In this episode, Holly Buckley, Chair of Healthcare at McGuireWoods, shares insights on deal activity across the healthcare market, including rising interest in home-based care, behavioral health, and digital health.

In this episode, Scott Becker discusses the sharp rise in Restoration Hardware’s stock and the contrasting downturn at GM.

In this episode, Scott Becker explores the value of being consistently dependable in work and life.

In this episode, Scott Becker reflects on an unexpected win with Astera Labs stock, emphasizing how sometimes luck plays a bigger role than strategy.

In this episode, Scott Becker discusses GM’s 7& stock drop following a 35% decline in operating income last quarter, as the company cites tariffs as a major factor. He also explores whether tariffs are truly to blame or simply a convenient scapegoat for deeper issues.

In this episode Michael Greeley, Co‑Founder and General Partner at Flare Capital, shares how his firm partners with entrepreneurs to reinvent healthcare technology, the rise and fall of digital health and AI waves, and what it takes to build, finance and exit enduring health tech ventures.

In this episode, Scott Becker breaks down how ongoing deficit spending by both Democratic and Republican administrations fuels market growth and creates a misleading sense of economic strength.

In this episode, Scott shares insights into the 5 largest US companies by revenue.

This episode covers five key stories including strong year-to-date gains for the S&P and NASDAQ, Stellantis’s $2.7 billion projected loss, Domino’s solid sales growth, and NVIDIA’s rise to the top spot in market capitalization.